SCHEMBL6934976

SCHEMBL6934976

COC[C@H](C)n1cc(I)cn1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACHE P22303 6/20 0.33
IDH1 O75874 1/20 0.30
IDH2 P48735 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6938298 1.00 ACHE (0.33) ACHEIDH1IDH2
SCHEMBL14329449 0.80 ACHE (0.34) ACHE
SCHEMBL14329364 0.80 ACHE (0.34) ACHE
SCHEMBL19222224 0.79 ACHE (0.39) ACHE
SCHEMBL25298957 0.79 ACHE (0.36) ACHE
SCHEMBL17076800 0.79 MEN1 (0.34) ACHE
SCHEMBL25791839 0.79 ACHE (0.36) ACHE
SCHEMBL15653049 0.79 MEN1 (0.34) ACHE
SCHEMBL25791847 0.79 ACHE (0.36) ACHE
SCHEMBL22531518 0.78 JAK2 (0.39) ACHEIDH1IDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011110545-A1 IMIDAZO [1, 2 -A] PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES JANSSEN PHARMACEUTICA NV (BE) 2011-09-15 WO disclosed